Research Article

Hypovolemic Status in Older Hip Fracture Patients Elucidated by Preoperative Transthoracic Echocardiography

Table 1

Demographic characteristics of patients with hip fracture and those who underwent total hip arthroplasty (THA).

Hip fracture (n = 167)THA (n = 44)P

Age (year)87.0 (83 − 91)82.5 (78 − 86)<0.01
Female139 (83.2)35 (79.5)0.656
Height (cm)150 (145 − 154)147 (140 − 153)0.180
Body weight (kg)44.0 (39.2–51.0)52.1 (43.6–59.6)<0.01
Body surface area (m2)1.34 (1.26–1.46)1.45 (1.33–1.55)<0.01
Hemoglobin (g/dL)11.5 (10.4–12.5)12.8 (11.8–13.1)<0.01
Hematocrit (%)34.5 (32.0–37.9)38.7 (36.0–40.9)<0.01
Beta-blocker medication19 (11.4)5 (11.4)0.999
Antiplatelet therapy29 (17.4)6 (13.6)0.654
Anticoagulant therapy12 (7.2)4 (9.1)0.749
Old myocardial infarction2 (1.2)1 (2.3)0.506
Chronic atrial fibrillation10 (6.0)1 (2.3)0.466
Maintenance hemodialysis0 (0.0)0 (0.0)0.999
Pacemaker implantation1 (0.6)1 (2.3)0.371
Moderate to severe AR and/or MR28 (16.8)8 (18.2)0.824
Moderate to severe TR and/or PR34 (20.4)6 (13.6)0.390

AR, aortic regurgitation; MR, mitral regurgitation; TR, tricuspid regurgitation; PR, pulmonic regurgitation.